Global Health News and Research

RSS

Global study to test whether antimalaria drug can prevent COVID-19 in health-care workers

With $9 million in philanthropic support, an international group of physicians and scientists is establishing a research network to evaluate promising therapies for COVID-19.

18 May 2020

New biodegradable antiviral filters developed for protective masks

The CSIC's associated unit in Polymer Technology in Castellón will study the biodegradation levels of the materials developed.

18 May 2020

Well-known cancer drugs may prevent SARS-CoV-2 viral replication say researchers

Researchers in Frankfurt, Germany, have described cell signaling events that occur when severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells and have identified pathways that are essential for the virus to replicate.

17 May 2020

Researchers create a simplified method to search for COVID-related clinical trials

Researchers at Columbia University have developed COVID-19 Trial Finder, a simplified method for patients, clinicians and healthy volunteers to search for appropriate COVID-related clinical trials in their general location.

15 May 2020

Study: Over 28 million elective operations could be cancelled due to COVID-19 pandemic

Over 28 million elective surgeries across the globe could be cancelled as a result of the COVID-19 pandemic – leading to patients facing a lengthy wait for their health issues to be resolved, a new study reveals.

15 May 2020

HVTN and HPTN initiate first clinical trial in response to COVID-19

The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19.

15 May 2020

SARS-CoV-2 will infect 250 million people in Africa

A study conducted by the World Health Organization (WHO) has predicted that the coronavirus will infect almost one-quarter of a billion people in Africa during the first year of the pandemic. Unless immediate measures are taken to control the spread of the virus, as many as 190,000 of them are likely to die, the researchers warn.

14 May 2020

New clinical trial to investigate the efficacy of ivermectin against COVID-19

Clínica Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, have launched a clinical trial to investigate the efficacy of ivermectin against COVID-19.

14 May 2020

Lessons for COVID-19 from 2009 H1N1

The world has experienced many outbreaks of viral diseases. Over the past two decades, we have also seen the emergence of zoonotic human respiratory coronaviruses with pandemic potential.

13 May 2020

Scientists discover how the iron chelator drives immune system to deal with TB

Although COVID-19 commands the headlines today, tuberculosis (TB) remains the biggest infection killer in the world and multiple drug resistant TB, which does not respond to regular antibiotics, continues to be a major threat to global health.

13 May 2020

Non-invasive ventilation mask could reduce aerosolization when treating COVID-19 patients

Led by Lawson Health Research Institute, London Health Sciences Centre, University Health Network and General Dynamics Land Systems-Canada, researchers have designed a non-invasive ventilation mask that could significantly reduce aerosolization - the production of airborne respiratory droplets that may contain viruses or bacteria - when treating patients with COVID-19.

13 May 2020

Largest study to date reveals risk factors for COVID-19 death

Academics at the University of Oxford and the London School of Hygiene & Tropical Medicine, working on behalf of NHS England and in partnership with NHSX, have analyzed the pseudonymized health data of over 17.4 million UK adults to discover the key factors associated with death from COVID-19 .

13 May 2020

New rapid CRISPR-based test for sensitive SARS-CoV-2 detection

A new study reports the approval of a new CRISPR-based coronavirus test that is both sensitive and rapid and intended to help reduce the time required to test symptomatic or potentially contagious cases.

13 May 2020

Sanford director receives major grant to advance broad-spectrum antivirals for respiratory diseases

Sanford Burnham Prebys Medical Discovery Institute is pleased to announce that Sumit Chanda, Ph.D., has received a $10.2 million, four-year grant from the Department of Defense to develop and advance broad-spectrum antivirals for respiratory diseases.

12 May 2020

Urbanization in India may be associated with increase in cardiometabolic risk factors

Although the health benefits of green space are supported by a growing body of evidence, few studies on this topic have been carried out in low- and middle-income countries.

11 May 2020

New biosensor system may hold the key to personal management of gout

In a recent article published in the February issue of the journal Sensors, researchers at Texas A&M University have reported a technology that might help people with gout disease monitor their symptoms better.

11 May 2020

Gum Health Day 2020 to be celebrated worldwide on 12 May

"Say NO to bleeding gums" is the slogan for Gum Health Day 2020, to be celebrated worldwide on 12 May. Its goal is to raise public awareness about bleeding gums, which are usually a sign of a gum disease that will require treatment at the dental practice.

11 May 2020

Expanding sick leave protection is crucial during the COVID-19 crisis

At a time when the world's attention is focused on curbing the spread of infectious disease, new research by the UCLA WORLD Policy Analysis Center shows that strengthening guarantees of paid sick leave is crucial to protecting health and economic security around the globe.

11 May 2020

Southwest CEO’s boast about airplanes’ low COVID risk flies by key concerns

During a May 3 appearance on "Face the Nation," Southwest CEO Gary Kelly said that he believed it was safe for Americans to fly during the coronavirus epidemic and that a plane is as safe as any other space.

11 May 2020

COVID-19 could accelerate activation of dormant tuberculosis (TB)

The ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has thrown much of the world into disarray, with over 4 million people reported infected and well over 282,000 deaths. A new study published on the preprint server bioRxiv in May 2020 suggests that the long-term impact of the virus could include activation of dormant bacterial infections like tuberculosis (TB).

10 May 2020